Revolution Medicines, Inc. (RVMD) /
The debt of Revolution Medicines, Inc. over the past 8 years
Chart Revolution Medicines, Inc.: liquid cash, total debt, net cash, fiscal 2018–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Revolution Medicines, Inc. had liquid cash of $2.03B and total debt of $0: net cash of $2.03B. It had more liquid cash than debt at all 7 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.03B* | $0 | $2.03B |
| 2024ended Dec 31, 2024 | $2.29B* | $0 | $2.29B |
| 2023ended Dec 31, 2023 | $1.85B* | $0 | $1.85B |
| 2022ended Dec 31, 2022 | $644.94M* | $0 | $644.94M |
| 2021ended Dec 31, 2021 | $577.05M* | $0 | $577.05M |
| 2020ended Dec 31, 2020 | $440.74M* | $0 | $440.74M |
| 2019ended Dec 31, 2019 | $122.76M* | $0 | $122.76M |
| 2018ended Dec 31, 2018 | — | — | — |
Fiscal years as Revolution Medicines, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Revolution Medicines, Inc.
- The revenue of Revolution Medicines, Inc.
- The profitability of Revolution Medicines, Inc.
- The cash flow of Revolution Medicines, Inc.
- All of Revolution Medicines, Inc.'s financials, charted
Companies of a similar size
- ELTHE ESTEE LAUDER COMPANIES INC.
- NBISNEBIUS GROUP N.V.
- PRUPRUDENTIAL FINANCIAL INC
- SYYSysco Corporation
- STMSTMicroelectronics N.V.
Not investment advice. This page shows what Revolution Medicines, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.